Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

0.00%

0.8¢ anagenics limited

Ann: Trading Halt-CDY.AX, page-25

First 25 Last

Share
Profile

Follow
kirsty78

568 Posts.

26/10/16

12:53

Post #: 20133659
Share

Originally posted by siren4 ↑

My take on the CR is twofold, both extremely positive for the sp:

Firstly, as Pharmag, Osi & Rickii suggest and as stated in the ann (page 2) it is simply money for business growth. Let's not rule out that this could be for one or both of the speciality subsidiaries. That is good. However, in all likelihood the CR is to fast track the US launch. It is probably Plan B as it was pretty clear for months to the Board that a strong take up of the options was unlikely.

Secondly, the CR is IMO to takeover proof CDY. That is good. The CR I think is to a strategic investor bullish enough about the stock's future to pay >$0.034 ps (perhaps as much as $0.04) for a large stake of at least 9% (my guess 100,000,000 shares at $0.035 to $0.04 ps to raise up to $4m; that issue price would avert duding recent options converters and enable the incoming investor to secure a foothold in this amazing small cap unappreciated by the market and on the cusp of a cheap sp being behind us. Already it seems that there are no remaining sellers at $0.033 or less.

Concurrently, the positive sentiment from the CR at above market would send a strong message at this turning point for CDY and lessen the dilution effect. The cornerstone investor is likely to be Pacific Edge or other licensee for its commercial protection. A wild card guess is a major pharma or indeed even CSL.

If I'm even half right on the above assessment the lifting of this Trading Halt should see CDY's sp on Friday or earlier run up above $0.04. I wish I had the $4m to take up this CR!

Expand

Cournerstone pharma co underwriting the ops? Now thats a huge positive!!

CDY Price at posting: 3.3¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 5 more messages in this thread...

First 25 Last

Add AN1 (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.690M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Trading Halt-CDY.AX, page-25

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Featured News

Ann: Trading Halt-CDY.AX, page-25

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Featured News